Erganeo is based on the fundamental idea that Public Research is more than ever essential to societal progress. Your projects have always made it possible to meet the huge challenges facing the world. To bring new futures to life, we offer you tailor-made support towards success and recognition.Discover our offer
The industry of tomorrow must be at the service of human progress. Erganeo reveals the full potential of what you want to develop by creating new applications to ensure the competitiveness and performance of your business: we offer concrete, useful and quickly marketable disruptive technologies to support an ethical and sustainable progress.Discover our offer
To meet the challenges of tomorrow, Erganeo takes the controlled risk of investing at the earliest in disruptive innovations with strong economic and societal potential. We will do everything to support these projects towards success: technological excellence, business performance, environmental and societal impact.Discover our offer
Our key figures
(*Figures of March 31st, 2022)
A co-exclusive license has been signed between Erganeo and companies Polyscope and Cube Biotech for the development and marketing of two versions of polymers that show improved solubilisation efficiencies of membrane proteins. This technology is of real value in biochemistry and pharmacology The ...
Erganeo participates in the global and virtuous evolution for the many. We dare to create new technological applications for companies and launch start-ups. Since its creation in 2012, Erganeo has invested more than €42 million in the emergence of disruptive innovations with a positive impact on society.
As a member of the SATT Network, Erganeo is laying the foundations of a desirable future in the Paris Region ecosystem, a pool of innovation rich of 20 000 researchers. Erganeo works to ensure that the Deep Tech innovations from our shareholders’ laboratories in the Paris Region reach maturity and access the market to benefit society.
Our core activity is based on a territory composed of teams of excellence in the Paris Region. We cover a wide range of scientific and technological expertise from multiple fields in more than 350 laboratories, including Biotech, Infotech and Enertech.
The device developed by Neurallys is a self-functioning pressure sensor implanted under the skin at the same time as the valve, located just upstream of it. It allows the transmission of intracranial pressure information to the doctor in case of worrying symptoms, via the patient's smartphone.